B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?

about

B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?

Item

http://www.wikidata.org/entity/Q48930054

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@en

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@nl

type

Item

label

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@en

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@nl

prefLabel

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@en

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@nl

P1476

B-type natriuretic peptide or ...... ailure: what is the next STEP?

@en

P2093

M Gary Nicholls

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of medications on circulating levels of cardiac natriuretic peptides

State of the art: using natriuretic peptide levels in clinical practice.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome.

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.

Eplerenone in patients with systolic heart failure and mild symptoms.

P304

1046-1048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/EURJHF/HFR117

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard W. Troughton

P577

2011-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21873341

http://www.w3.org/2001/XMLSchema#string

P921

heart failure